The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.
J. P. Neoptolemos
No relevant relationships to disclose
M. J. Moore
No relevant relationships to disclose
T. F. Cox
No relevant relationships to disclose
J. W. Valle
No relevant relationships to disclose
D. H. Palmer
No relevant relationships to disclose
A. Mcdonald
No relevant relationships to disclose
R. Carter
No relevant relationships to disclose
N. C. Tebbutt
No relevant relationships to disclose
C. Dervenis
No relevant relationships to disclose
D. Smith
No relevant relationships to disclose
B. Glimelius
No relevant relationships to disclose
F. Y. Coxon
No relevant relationships to disclose
F. Lacaine
No relevant relationships to disclose
M. R. Middleton
No relevant relationships to disclose
P. Ghaneh
No relevant relationships to disclose
C. Bassi
No relevant relationships to disclose
C. Halloran
No relevant relationships to disclose
A. Olah
No relevant relationships to disclose
C. L. Rawcliffe
No relevant relationships to disclose
M. W. Büchler
No relevant relationships to disclose